Cision PR Newswire

Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy

First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in human skeletal muscle in a monogenic disease. Paired muscle biopsies reveal 3.5- to 5.3-fold increases in sarcolemmal utrophin expression, accompanied by definitive tissue histopathological...

Vatrer Power to Showcase Lithium Golf Cart Battery Conversion Kits at 2026 Golf Carting Expo & Dealer Summit

LAS VEGAS and CHARLESTON, S.C., Oct. 3, 2026 /PRNewswire/ -- Vatrer Power, a provider...

Property Management of Chulalongkorn University Shapes a Sustainable District Through Shared Value and Innovation

BANGKOK, Oct. 3, 2026 /PRNewswire/ -- A thriving district is more than the buildings...

PEA Powers Thailand’s Sustainable Energy Future Through a Brand Built on Trust, Innovation, and Meaningful Impact

BANGKOK, Oct. 3, 2026 /PRNewswire/ -- A trusted brand is built through every interaction,...

RSM Singapore’s Scholarship Endowment Fund to Support Disadvantaged Students

SINGAPORE, Aug. 4, 2025 /PRNewswire/ -- Students from disadvantaged families will now have a boost to receive higher education, as RSM Singapore has pledged to...

Advancing Global Tourism Industry Trade: Tourism Plus Shanghai 2026 Calls for Worldwide Exhibitors

SHANGHAI, Aug. 4, 2025 /PRNewswire/ -- From March 29th to April 3rd, 2026, Tourism Plus Shanghai (TPS 2026) will convene over 6,000 global exhibitors in...

RHB, TOKIO MARINE LIFE AND TAKAFUL MALAYSIA FORGE LONG TERM EXCLUSIVE BANCA PARTNERSHIPS

KUALA LUMPUR, Malaysia, Aug. 4, 2025 /PRNewswire/ -- RHB Banking Group ("RHB" or the "Group") entered into bancassurance and bancatakaful partnerships with Tokio Marine Life...

Alphamab Oncology Announces IND Application for Innovative PD-L1/αvβ6 Bispecific ADC JSKN022 was Officially Accepted by CDE

SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN022, an independently...